Winstrol 50 mg 50 Tablets Nakon Medical USA
$79.00
Product Short Description
Winstrol 50 mg 50 Tablets Nakon Medical USA delivers stanozolol (C21H32N2O) exhibiting extreme anabolic potency (~320:30 ratio) at premium oral 50 mg strength matching institutional performance specifications. Domestic production serves DEA Schedule III compliant channels exclusively.
Product Overview
Nakon Medical USA’s Winstrol 50 mg presents stanozolol, featuring C2-C3 pyrazole substitution preventing aromatization characteristic of 17α-methylated DHT derivatives (~8-hour half-life), in USP-equivalent scored tablets for institutional catalogs. The 50-tablet tamper-evident configuration supports CIII-compliant inventory management across encrypted specialist platforms requiring batch traceability essential for DEA-regulated workflows.
U.S. domestic manufacturing eliminates customs exposure distinguishing legitimate Schedule III supply from underground tablet presses prevalent in non-verified markets. High-dosage format serves advanced resellers managing controlled substance inventories rather than discontinued prescription Winstrol (2 mg).
Brand & Manufacturer Information
Nakon Medical USA produces Schedule III anabolics through domestic facilities serving institutional performance distribution requiring controlled substance compliance. Winstrol 50 mg maintains catalog continuity alongside Nakon Primo authenticating legitimate institutional supply versus powder-converted alternatives.
Active Compound Information
Contains stanozolol (17α-methyl-2’H-5α-androst-2-enopyrazol-17β-ol), heterocyclic DHT derivative enabling high anabolic:androgenic dissociation with no estrogen conversion and moderate hepatotoxicity profile characteristic of 17α-methylated oral steroids. DEA Schedule III (21 CFR 1308.13) reflects performance dosage escalation potential.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Winstrol 50 mg 50 Tablets Nakon Medical USA |
| Active Compound | Stanozolol (C21H32N2O) |
| Strength | 50 mg per scored tablet |
| Quantity | 50 tablets per bottle |
| Form | Oral scored tablets |
| Category | DEA Schedule III controlled substance |
| Packaging | Tamper-evident HDPE bottle |
Legal & Regulatory Disclaimer
Stanozolol constitutes DEA Schedule III under 21 USC §812; non-medical handling violates Controlled Substances Act. Buyer assumes Form 222 compliance; zero medical claims provided.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Reviews
There are no reviews yet.